Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Werewolf Therapeutics is a biopharmaceutical company developing innovative immunotherapies for cancer and immune-mediated diseases. Using its proprietary PREDATOR platform, it engineers conditionally activated cytokine molecules (INDUKINE) that target the tumor microenvironment, aiming to enhance efficacy while minimizing toxicity. Its pipeline includes cytokine-based therapeutics like IL-2, IL-12, IL-21, IL-18, and IL-10, designed for systemic delivery and tumor-specific activation. The company focuses on immuno-oncology, autoimmune, and inflammatory disease treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.